Pharmaceuticals, Biotechnology and Life Sciences
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes high quality in vivo services for biotechs, pharmaceutical companies and academics.
The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about testing:
Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, is preparing to open its Technology Excellence Center in Boston (US TEC), Massachusetts.
LONDON–(BUSINESS WIRE)–#AlprazolamMarket–The alprazolam market is poised to grow by USD 90.33 million during 2020-2024, progressing at a CAGR of over…
Request FREE Proposal for Comprehensive Insights LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions…
NAARDEN, Netherlands & HERZLIYA, Israel–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative…
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Diana McKenzie has been appointed to its board of directors as…
– European approval is based on the Phase 3 BEACON CRC trial that demonstrated a significant improvement in overall survival…
Octapharma USA Extends Funding for COVID-19 Study Following Positive Preliminary Research Data
